Re: Stakeholder Groups Urge the FDA to Pass Regulation on Laboratory-Developed Tests

Letter to Robert M. Califf M.D., MACC, Commissioner, U.S. Food and Drug Administration

CSPI writes on behalf of a broad group of public interest organizations to urge the Food and Drug Administration (FDA) to develop regulations for laboratory-developed tests (LDTs) in the event that legislation to regulate such tests does not progress in Congress.

View resource